{"id":"https://openalex.org/W2045951807","doi":"https://doi.org/10.1081/cnv-200029066","title":"A Phase I Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients: A Hoosier Oncology Group Study","display_name":"A Phase I Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients: A Hoosier Oncology Group Study","alternate_titles":[],"publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2045951807","doi":"https://doi.org/10.1081/cnv-200029066","mag":"2045951807","pmid":"https://pubmed.ncbi.nlm.nih.gov/15493359"},"language":"en","primary_location":{"id":"doi:10.1081/cnv-200029066","doi":"https://doi.org/10.1081/cnv-200029066","is_oa":false,"landing_page_url":"https://doi.org/10.1081/cnv-200029066","pdf_url":null,"source":{"id":"https://openalex.org/S121125331","display_name":"Cancer Investigation","issn_l":"0735-7907","issn":["0735-7907","1532-4192"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Investigation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2045951807"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043417015","display_name":"Steven D. Passik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]},{"id":"https://openalex.org/I4210122680","display_name":"Hoosier Cancer Research Network (United States)","ror":"https://ror.org/02mtpb511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122680"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven D. Passik","raw_affiliation_strings":["Hoosier Oncology Group, Walther Cancer Institute, Indianapolis, Indiana, USA. spassik@uky.edu","Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","Symptom Management and Palliative Care Program, Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, Markey Cancer Center, University of Kentucky, 800 Rose St.-CC125, Lexington, Kentucky, 40536-0093, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, Indianapolis, Indiana, USA. spassik@uky.edu","institution_ids":["https://openalex.org/I4210122680"]},{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","institution_ids":["https://openalex.org/I4210122680"]},{"raw_affiliation_string":"Symptom Management and Palliative Care Program, Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, Markey Cancer Center, University of Kentucky, 800 Rose St.-CC125, Lexington, Kentucky, 40536-0093, USA","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076594436","display_name":"Rudolph M. Navari","orcid":"https://orcid.org/0000-0002-8513-896X","observed_orcids":["https://orcid.org/0000-0002-8513-896X"]},"institutions":[{"id":"https://openalex.org/I4210122680","display_name":"Hoosier Cancer Research Network (United States)","ror":"https://ror.org/02mtpb511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122680"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rudolph M. Navari","raw_affiliation_strings":["Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA","Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA","institution_ids":["https://openalex.org/I4210122680"]},{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","institution_ids":["https://openalex.org/I4210122680"]},{"raw_affiliation_string":"Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023554560","display_name":"Sin\u2010Ho Jung","orcid":"https://orcid.org/0000-0002-1473-7236","observed_orcids":["https://orcid.org/0000-0002-1473-7236"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sin-Ho Jung","raw_affiliation_strings":["Department of Biostatistics and Bioinformatics, Duke University, Durham, North CarolinaUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Bioinformatics, Duke University, Durham, North CarolinaUSA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007244658","display_name":"Cindy K Nagy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122680","display_name":"Hoosier Cancer Research Network (United States)","ror":"https://ror.org/02mtpb511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122680"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cindy Nagy","raw_affiliation_strings":["Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA","Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA","institution_ids":["https://openalex.org/I4210122680"]},{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","institution_ids":["https://openalex.org/I4210122680"]},{"raw_affiliation_string":"Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049887030","display_name":"Jake Vinson","orcid":"https://orcid.org/0009-0000-0405-7854","observed_orcids":["https://orcid.org/0009-0000-0405-7854"]},"institutions":[{"id":"https://openalex.org/I4210122680","display_name":"Hoosier Cancer Research Network (United States)","ror":"https://ror.org/02mtpb511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122680"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jake Vinson","raw_affiliation_strings":["Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","institution_ids":["https://openalex.org/I4210122680"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050413965","display_name":"Kenneth L. Kirsh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenneth L. Kirsh","raw_affiliation_strings":["Symptom Management and Palliative Care Program, Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, Markey Cancer Center, University of Kentucky, 800 Rose St.-CC125, Lexington, Kentucky, 40536-0093, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Symptom Management and Palliative Care Program, Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, Markey Cancer Center, University of Kentucky, 800 Rose St.-CC125, Lexington, Kentucky, 40536-0093, USA","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021904320","display_name":"Patrick Joseph Loehrer","orcid":"https://orcid.org/0000-0002-1532-4660","observed_orcids":["https://orcid.org/0000-0002-1532-4660"]},"institutions":[{"id":"https://openalex.org/I4210122680","display_name":"Hoosier Cancer Research Network (United States)","ror":"https://ror.org/02mtpb511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122680"]},{"id":"https://openalex.org/I4390039234","display_name":"Indiana University Melvin and Bren Simon Comprehensive Cancer Center","ror":"https://ror.org/00g1d7b60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039234","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick Loehrer","raw_affiliation_strings":["Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Indiana University Cancer Center, 535 Barnhill Dr. RT 473, Indianapolis, Indiana, 46202, USA","Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","Indiana University Cancer Center, 535 Barnhill Dr. RT 473, Indianapolis, Indiana, 46202, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Indiana University Cancer Center, 535 Barnhill Dr. RT 473, Indianapolis, Indiana, 46202, USA","institution_ids":["https://openalex.org/I4210122680","https://openalex.org/I4390039234"]},{"raw_affiliation_string":"Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA","institution_ids":["https://openalex.org/I4210122680"]},{"raw_affiliation_string":"Indiana University Cancer Center, 535 Barnhill Dr. RT 473, Indianapolis, Indiana, 46202, USA","institution_ids":["https://openalex.org/I4390039234"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.2959,"has_fulltext":false,"cited_by_count":109,"citation_normalized_percentile":{"value":0.93689777,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"22","issue":"3","first_page":"383","last_page":"388"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/delayed-emesis","display_name":"delayed emesis","score":0.9409999847412109},{"id":"https://openalex.org/keywords/chemotherapy-induced-nausea-and-vomiting","display_name":"chemotherapy-induced nausea and vomiting","score":0.9470000267028809},{"id":"https://openalex.org/keywords/antiemetic-prophylaxis","display_name":"antiemetic prophylaxis","score":0.9359999895095825},{"id":"https://openalex.org/keywords/highly-emetogenic-chemotherapy","display_name":"highly emetogenic chemotherapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/moderately-emetogenic-chemotherapy","display_name":"moderately emetogenic chemotherapy","score":0.9589999914169312},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6299999952316284},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9409999847412109},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.671999990940094},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9259999990463257},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9940000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8242136240005493},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6242825984954834},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.5979220271110535},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5961036682128906},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5475202798843384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48440057039260864},{"id":"https://openalex.org/C2780884295","wikidata":"https://www.wikidata.org/wiki/Q575136","display_name":"Antiemetic","level":3,"score":0.47721248865127563},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4733474552631378},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39748018980026245},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000855","descriptor_name":"Anorexia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000932","descriptor_name":"Antiemetics","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000932","descriptor_name":"Antiemetics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019964","descriptor_name":"Mood Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1081/cnv-200029066","doi":"https://doi.org/10.1081/cnv-200029066","is_oa":false,"landing_page_url":"https://doi.org/10.1081/cnv-200029066","pdf_url":null,"source":{"id":"https://openalex.org/S121125331","display_name":"Cancer Investigation","issn_l":"0735-7907","issn":["0735-7907","1532-4192"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Investigation","raw_type":"journal-article"},{"id":"pmid:15493359","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15493359","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer investigation","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W134470079","https://openalex.org/W1929570960","https://openalex.org/W1966152590","https://openalex.org/W1979700184","https://openalex.org/W1985517071","https://openalex.org/W1994746818","https://openalex.org/W2027393266","https://openalex.org/W2078294506","https://openalex.org/W2085892023","https://openalex.org/W2105258029","https://openalex.org/W2165031861","https://openalex.org/W2260510125","https://openalex.org/W2299629815","https://openalex.org/W2333961811","https://openalex.org/W2470094082"],"related_works":["https://openalex.org/W2143726677","https://openalex.org/W2029309368","https://openalex.org/W2597655632","https://openalex.org/W2357728951","https://openalex.org/W2765254826","https://openalex.org/W2460792208","https://openalex.org/W4405406800","https://openalex.org/W4233221478","https://openalex.org/W2468921442","https://openalex.org/W2140767828"],"abstract_inverted_index":{"Chemotherapy-induced":[0],"delayed":[1],"emesis":[2],"(DE)":[3],"can":[4,38],"affect":[5],"up":[6],"to":[7,9,31,42,47,79,119,181],"50%":[8],"70%":[10],"of":[11,34,77,87,96,99,129,136,167,171,197,212,231,243],"patients":[12,81,91,106,148,160,199,214],"receiving":[13,92,200,215],"moderately":[14,216],"and":[15,37,55,116,121,139,158,188,190,210],"highly":[16,201],"emetogenic":[17,202,217],"chemotherapy,":[18],"although":[19],"rates":[20],"are":[21],"improving.":[22],"DE":[23,88],"most":[24],"commonly":[25],"occurs":[26],"within":[27],"the":[28,85,150,174,241],"first":[29,94],"24":[30],"48":[32],"hours":[33],"chemotherapy":[35,97,120,203,218],"administration":[36],"persist":[39],"for":[40,84,123,240],"2":[41],"5":[43,183],"days.":[44],"Olanzapine,":[45],"due":[46],"its":[48],"activity":[49],"at":[50,143],"multiple":[51],"dopaminergic,":[52],"serotonergic,":[53],"muscarinic,":[54],"histaminic":[56],"receptor":[57],"sites,":[58],"has":[59],"potential":[60],"as":[61,131,133],"antiemetic":[62],"therapy.":[63],"A":[64,246],"phase":[65,247],"I":[66],"study":[67],"was":[68,111],"designed":[69],"with":[70],"olanzapine,":[71],"using":[72],"a":[73,162,168],"four-cohort":[74],"dose":[75,145,179],"escalation":[76],"3":[78],"6":[80],"per":[82],"cohort,":[83],"prevention":[86,242],"in":[89],"cancer":[90],"their":[93],"cycle":[95],"consisting":[98],"cyclophosphamide,":[100],"doxorubicin,":[101],"platinum,":[102],"and/or":[103],"irinotecan.":[104],"All":[105],"received":[107],"standard":[108],"premedication.":[109],"Olanzapine":[110],"administered":[112],"on":[113],"days":[114,125,186,194],"-2":[115,187],"-1":[117],"prior":[118],"continued":[122],"8":[124],"(days":[126],"0-7).":[127,195],"Episodes":[128],"vomiting":[130,229],"well":[132],"daily":[134],"measurements":[135],"nausea,":[137],"sedation,":[138],"toxicity":[140,164],"were":[141,156],"monitored":[142],"each":[144],"level.":[146],"Fifteen":[147],"completed":[149],"protocol.":[151],"No":[152],"grade":[153],"4":[154],"toxicities":[155],"seen,":[157],"three":[159],"experienced":[161],"dose-limiting":[163],"(grade":[165],"3)":[166],"depressed":[169],"level":[170],"consciousness":[172],"during":[173],"study.":[175],"The":[176],"maximum":[177],"tolerated":[178],"appeared":[180],"be":[182,236],"mg":[184,192],"(for":[185,193],"-1)":[189],"10":[191],"Four":[196],"six":[198],"(cisplatin,":[204],">":[205,220],"or":[206,221],"=":[207,222],"70":[208],"mg/m2)":[209,224],"nine":[211,213],"(doxorubicin,":[219],"50":[223],"had":[225],"complete":[226],"control":[227],"(no":[228],"episodes)":[230],"DE.":[232,245],"Therefore,":[233],"olanzapine":[234],"may":[235],"an":[237],"effective":[238],"agent":[239],"chemotherapy-induced":[244],"II":[248],"trial":[249],"is":[250],"underway.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2045951807","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
